FDA recall (Class II): Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Su…
FDA recalls compounded GLP-1 product for sterility issues.
What changed & why it matters
Med Spa Radar recorded an FDA enforcement action at the federal level, dated July 2, 2025, in the GLP-1 Compounding category, naming Semaglutide.
A recall of Semaglutide is a supply-chain event, not a rule that might change: if the pharmacy or outsourcing facility a med spa sources from distributed an affected lot, it is a patient-safety and liability exposure today. Recalls are the clearest signal that a supplier a practice may already use has a quality problem on record with the FDA.
- Type
- FDA Enforcement
- Jurisdiction
- Federal
- Category
- GLP-1 Compounding
- Substance
- Semaglutide
- Recorded
- July 2, 2025
What this means for your specific practice — the exact step to take, the deadline to calendar, or the supplier detail to check — is in the member "what to do" below. This page is the free record of what changed and why it matters.
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
FDA Enforcement · primary source ↗
Related alerts
- FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, Ks 66061,…
- FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
- FDA recall (Class II): Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, …
- FDA recall (Class II): Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo…
- FDA recall (Class II): Wegovy (Semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
- FDA recall (Class II): Wegovy (Semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …
Monitoring, not legal advice.